Similarly, in CD34+ leukemic stem cells (LSCs) derived from patients with chronic myeloid leukemia, metabolic analysis revealed increased levels of OXPHOS compared to CD34− cells, while inhibition of this process resulted in their selective eradication in vitro [28]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.